Akeso, Inc
ISIN KYG0146B1032
|WKN A2P200
Market cap (in EUR)
8,637.79 m
Country
China
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. It operates through the following geographical segments: Chinese Mainland, USA, and Other Regions. The company was founded by Yu Xia, Peng Zhang, Baiyong Li, and Zhongmin Wang in March 2012 and is headquartered in Zhongshan, China.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals China
Financials
Key metrics
| Market capitalisation, EUR | 8,637.79 m |
| EPS, EUR | - |
| P/B ratio | 10.43 |
| P/E ratio | 17.42 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 272.83 m |
| Net income, EUR | -66.09 m |
| Profit margin | -24.22% |
What ETF is Akeso, Inc in?
There are 96 ETFs which contain Akeso, Inc. All of these ETFs are listed in the table below. The ETF with the largest weighting of Akeso, Inc is the UBS ETF (LU) Solactive China Technology UCITS ETF (hedged to EUR) A-acc.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
